FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

Extreme exercise 'not best way to lose weight' Aug 27, 5:13 pm
London, August 27 (ANI): A new study has found that extreme exercise may not help in reducing weight, in fact, it may do the opposite.
Full Story
Now, a fibre-satiety product that makes you eat less Aug 27, 1:01 pm
Washington, Aug 27 (ANI): Scientists have tested the effectiveness of a fibre-based dietary ingredient that makes people feel less hungry and consume less food.
Full Story
14th century Venice plague holds' lessons' for fight against Ebola Aug 27, 1:01 pm
London, Aug 27 (ANI): A new study has shed light into how to fight against today's Ebola outbreak in South Africa by revising methods used by Venice city to deal with its plague outbreak in the 14th century.
Full Story
Eyes are window into dementia Aug 26, 3:06 pm
Washington, Aug 26 (ANI): A new study has found that changes in the eye could help predict dementia, even before the symptoms show.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY